Skip to main content Help with accessibility Skip to main navigation

High Cost Drugs

Here you will find the Funding Position of CCG Commissioned High-Cost Drugs within the Lancashire and South Cumbria Health Economy

A number of High-Cost Drugs, devices, procedures and products have been excluded from the scope of the national tariff of Payment by Results. These are listed on tab 18 of the following document:

Annex A:2019/20 Nation Prices And Nation Tariff Workbook

High-cost drugs are commissioned by:

  • NHS England or

  • Clinical Commissioning Groups

The funding position of medicines directly commissioned by NHS England can be accessed via the NHS England website

Refer to the Manual for Prescribed Specialised Services for further information about prescribed specialised services, some of which are directly commissioned by NHS England and some by CCGs.

 

Red
Red
Red
Red
Red
Red
Red
Red
Red
Date Posted: 01 - Oct - 2019
Approval Mechanism: Prior approval blueteq form available
Black
Black
Black
Black
Black
Black
Black
Black
Black
Date Posted: 05 - Mar - 2020
Approval Mechanism:
Red
Red
Red
Red
Red
Red
Red
Red
Red
Date Posted: 05 - Mar - 2020
Approval Mechanism: Prior Approval Blueteq Form Available
Red
Red
Red
Red
Red
Red
Red
Red
Red
Date Posted: 01 - Oct - 2019
Approval Mechanism: Prior approval blueteq form available
Black
Black
Black
Black
Black
Black
Black
Black
Black
Date Posted: 05 - Mar - 2020
Approval Mechanism:
Red
Red
Red
Red
Red
Red
Red
Red
Red
Date Posted: 05 - Mar - 2020
Approval Mechanism: Prior Approval Blueteq Form Available
Red
Red
Red
Red
Red
Red
Red
Red
Red
Date Posted: 01 - Sep - 2018
Approval Mechanism: Blueteq
Red
Red
Red
Red
Red
Red
Red
Red
Red
Date Posted: 01 - Sep - 2018
Approval Mechanism: Blueteq
Grey
Pending
Grey
Grey
Pending
Grey
Grey
Grey
Grey
Date Posted: 01 - Jul - 2018
Approval Mechanism:
Grey
Pending
Grey
Grey
Pending
Grey
Grey
Grey
Grey
Date Posted: 01 - Jul - 2018
Approval Mechanism: